Page last updated: 2024-10-30

lamotrigine and Mucopolysaccharidosis III

lamotrigine has been researched along with Mucopolysaccharidosis III in 1 studies

Mucopolysaccharidosis III: Mucopolysaccharidosis characterized by heparitin sulfate in the urine, progressive mental retardation, mild dwarfism, and other skeletal disorders. There are four clinically indistinguishable but biochemically distinct forms, each due to a deficiency of a different enzyme.

Research Excerpts

ExcerptRelevanceReference
"We report the case of a 16-year-old male with Mucopolysaccharidosis III type A (Sanfilippo syndrome) who was commenced on risperidone for behaviour management."3.75Extrapyramidal symptoms and medication use in Mucopolysaccharidosis type III. ( Sillence, D; Tchan, MC, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tchan, MC1
Sillence, D1

Other Studies

1 other study available for lamotrigine and Mucopolysaccharidosis III

ArticleYear
Extrapyramidal symptoms and medication use in Mucopolysaccharidosis type III.
    Journal of intellectual & developmental disability, 2009, Volume: 34, Issue:3

    Topics: Adolescent; Adult; Anticonvulsants; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; C

2009